PP
ADAP

Paloma Partners’s Adaptimmune Therapeutics ADAP Stock Holding History

Paloma Partners’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-27,400
Closed -$33K – 1073
2019
Q4 		$33K Buy
+27,400
New +$33K ﹤0.01% 1787
2017
Q2 		– Sell
-30,000
Closed -$165K – 1608
2017
Q1 		$165K Buy
+30,000
New +$165K ﹤0.01% 1407